META

Meta Platforms, Inc.

Nasdaq · Services-Computer Programming, Data Processing, Etc. · Inc. DE · CIK 0001326801
$593.00 -5.51% $1.6T
Insider Selling Cluster (5 insiders)High Impact Filing (7/10)3 New Institutional Positions3 Institutional ExitsCongressional Activity (2)
Vol
Market Cap$1.6T
Cap SizeMega Cap
Inst. Holders13 funds
Inst. Value$292.6B
Inst. Activity3 buys / 3 sells
Insider Activity0B / 8S
Insider Net $-$5.0M
Reddit Sentiment50° Neutral
SEC Reports20
Congressional10 trades
Exchange Nasdaq·Sector Services-Computer Programming, Data Processing, Etc.·Inc. DE·CIK 0001326801·Prev Close $627.57

Recent Activity

Jul 28, 2026 earnings_calendar
META Q2 2026 Earnings After Market Close — 2026-07-28
EPS est: $7.37 | Rev est: $60.7B
Jun 3, 2026 SEC
Two Meta C-suite executives (COO and CLO) sold a combined $1.79M in open-market sales over the past week. At $1.52T mark
CLUSTER — Impact 2/10
Jun 3, 2026 Event
Layout, Inc. v. Heavy Metal Corp.
Court ruling from Appellate Division of the Supreme Court of the State of New York. Docket: 2021-049
Jun 1, 2026 Insider
Olivan Javier sold 837 shares
Chief Operating Officer @ $629.29 ($526.7K)
Jun 1, 2026 Insider
KIMMITT ROBERT M sold 504 shares
Director @ $629.29 ($317.2K)
May 31, 2026 SEC
DA Davidson initiates META at Buy — PT $600 (-5.1%)
ANALYST-UPGRADE — Impact 2/10
May 27, 2026 Insider
Mahoney Curtis J. sold 2,079 shares
Chief Legal Officer @ $609.92 ($1.3M)
May 1, 2026 SEC
Four firms act on META in cluster — DA Davidson initiates Buy with $600 PT (below current); consensus still bullish with mean target $855
ANALYST-UPGRADE — Impact 2/10

Price Targets

Historical data — last covering-analyst action Sep 2024. No current recommendation available.
$828.80 (Sep 2024)
Current $593.00 Low $700.00 Median $825.00 High $1,015.00 59 analysts
$700.00 $1,015.00

Analyst Ratings

Historical distribution88% buy · 72 analysts · last covering-analyst action Sep 2024
22Strong Buy
41Buy
9Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Sep 30, 2024 Cantor Fitzgerald REITERATE Overweight → Overweight
Sep 30, 2024 Monness, Crespi, Hardt MAINTAIN Buy → Buy
Sep 26, 2024 Rosenblatt MAINTAIN Buy → Buy
Sep 26, 2024 B of A Securities MAINTAIN Buy → Buy
Sep 26, 2024 JP Morgan MAINTAIN Overweight → Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $7.20 $5.76 — $8.55 1% YoY 46
Next Q $7.04 $6.05 — $8.99 571% YoY 44
Current FY $32.90 ▲ +0.8% $29.61 — $38.62 40% YoY 55
Next FY $34.90 ▲ +0.9% $30.22 — $40.86 6% YoY 54

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$132.0B
FMR LLC$80.8B
MORGAN STANLEY$24.8B
NORGES BANK$22.2BNEW
BANK OF AMERICA CORP$12.1B

Recent Insider Trades

DateInsiderTypeValue
Jun 1, 2026Olivan JavierSELL$526.7K
Jun 1, 2026KIMMITT ROBERTSELL$317.2K
May 27, 2026Mahoney CurtisSELL$1.3M
May 26, 2026Olivan JavierSELL$509.7K
May 18, 2026LI SUSANSELL$318.0K

Reddit Sentiment

50°
Neutral
Bearish Neutral Bullish
33 mentions 16 bullish 16 bearish

Congressional Trades

7 members: 8 buys, 2 sells
MemberPartyTypeAmount
Michael McCaulRBUY$1,001 - $15,000
Ro KhannaDBUY$1,001 - $15,000
Ro KhannaDSELL$1,001 - $15,000
13 institutional holders with $292.6B total value (443,295,008 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC199,995,630$132.0B45.1%
2FMR LLC122,341,612$80.8B27.6%
3MORGAN STANLEY37,553,102$24.8B8.5%
4NORGES BANK33,559,173$22.2B7.6%NEW
5BANK OF AMERICA CORP /DE/18,364,541$12.1B4.1%
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC15,559,200$10.3B3.5%NEW
7WELLS FARGO & COMPANY/MN9,855,423$6.5B2.2%ADD +28.5%
8DODGE & COX5,019,837$3.3B1.1%ADD +26.7%
9Mawer Investment Management Ltd.688,205$454.3M0.2%NEW
10TWO SIGMA INVESTMENTS, LP239,800$158.3M0.1%TRIM -31.2%
11CAUSEWAY CAPITAL MANAGEMENT LLC110,385$72.9M0.0%ADD +27.0%
12Corvex Management LP2,400$1.6M0.0%EXIT -100.0%
13Olstein Capital Management, L.P.5,700$3.8K0.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
NORGES BANKNEW33,559,173$22.2B2025-Q4
DODGE & COXADD3,963,2075,019,837+26.7%$3.3B2025-Q4
TWO SIGMA INVESTMENTS, LPTRIM348,324239,800-31.2%$158.3M2025-Q4
CAUSEWAY CAPITAL MANAGEMENT LLCADD86,917110,385+27.0%$72.9M2025-Q4
RENAISSANCE TECHNOLOGIES LLCEXIT482,4990-100.0%$0.002025-Q4
Duquesne Family Office LLCEXIT76,1000-100.0%$0.002025-Q4
RENAISSANCE TECHNOLOGIES LLCDOUBLED12,435482,499+3780.2%$354.3M2025-Q3
Duquesne Family Office LLCNEW76,100$55.9K2025-Q3
NORGES BANKEXIT31,372,0450-100.0%$0.002025-Q3
NORGES BANKNEW31,372,045$23.2B2025-Q2
Mawer Investment Management Ltd.NEW735,898$543.2M2025-Q2
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT598,27712,435-97.9%$9.2M2025-Q2
WELLS FARGO & COMPANY/MNADD5,983,2427,689,449+28.5%$4.4B2025-Q1
RENAISSANCE TECHNOLOGIES LLCDOUBLED49,858598,277+1100.0%$344.8M2025-Q1
NORGES BANKEXIT34,072,0260-100.0%$0.002025-Q1
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT647,42449,858-92.3%$29.2M2024-Q4
Corvex Management LPEXIT2,4000-100.0%$0.002024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW13,827,565$7.9B2024-Q3
19 unique insiders with 8 transactions. Net insider value: -$5.0M ($0.00 bought, $5.0M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 1, 2026Olivan JavierChief Operating OfficerSELL837$629.29$526.7K
Jun 1, 2026KIMMITT ROBERT MDirectorSELL504$629.29$317.2K
May 27, 2026Mahoney Curtis J.Chief Legal OfficerSELL2,079$609.92$1.3M
May 26, 2026Olivan JavierChief Operating OfficerSELL837$608.98$509.7K
May 18, 2026LI SUSAN JChief Financial OfficerSELL526$604.63$318.0K
May 18, 2026Bosworth AndrewChief Technology OfficerSELL400$604.51$241.8K
May 18, 2026Olivan JavierChief Operating OfficerSELL837$609.35$510.0K
May 15, 2026Alford PeggyDirectorM600$0.00$0.00
May 15, 2026Alford PeggyDirectorM600$0.00$0.00
May 15, 2026Collison PatrickDirectorM103$0.00$0.00
May 15, 2026Collison PatrickDirectorM103$0.00$0.00
May 15, 2026Houston AndrewDirectorM600$0.00$0.00
May 15, 2026Houston AndrewDirectorM600$0.00$0.00
May 15, 2026Killefer NancyDirectorM600$0.00$0.00
May 15, 2026Killefer NancyDirectorM600$0.00$0.00
May 15, 2026TAN HOCK EDirectorM167$0.00$0.00
May 15, 2026TAN HOCK EDirectorM167$0.00$0.00
May 15, 2026Travis Tracey ThomasDirectorM600$0.00$0.00
May 15, 2026Travis Tracey ThomasDirectorM600$0.00$0.00
May 15, 2026White DanaDirectorM109$0.00$0.00
May 15, 2026White DanaDirectorM109$0.00$0.00
May 15, 2026Arnold John DouglasDirectorM167$0.00$0.00
May 15, 2026Xu TonyDirectorM600$0.00$0.00
May 15, 2026Xu TonyDirectorM600$0.00$0.00
May 15, 2026Arnold John DouglasDirectorM167$0.00$0.00
May 15, 2026Andreessen Marc LDirectorM480$0.00$0.00
May 15, 2026Andreessen Marc LDirectorM480$0.00$0.00
May 15, 2026Elkann JohnDirectorM109$0.00$0.00
May 15, 2026KIMMITT ROBERT MDirectorM600$0.00$0.00
May 15, 2026Songhurst CharlesDirectorF108$618.43$66.8K
May 15, 2026Songhurst CharlesDirectorM109$0.00$0.00
May 15, 2026Elkann JohnDirectorF77$618.43$47.6K
May 15, 2026Elkann JohnDirectorM109$0.00$0.00
May 15, 2026KIMMITT ROBERT MDirectorM600$0.00$0.00
May 15, 2026Songhurst CharlesDirectorM109$0.00$0.00
May 15, 2026Anderson AaronChief Accounting OfficerM1,451$0.00$0.00
May 15, 2026Anderson AaronChief Accounting OfficerF1,218$618.43$753.2K
May 15, 2026Anderson AaronChief Accounting OfficerM1,451$0.00$0.00
May 15, 2026LI SUSAN JChief Financial OfficerC2,399$0.00$0.00
May 15, 2026LI SUSAN JChief Financial OfficerSELL2,127$618.43$1.3M
May 15, 2026LI SUSAN JChief Financial OfficerM6,791$0.00$0.00
May 15, 2026LI SUSAN JChief Financial OfficerF6,921$618.43$4.3M
May 15, 2026Cox Christopher KChief Product OfficerF8,127$618.43$5.0M
May 15, 2026Bosworth AndrewChief Technology OfficerM6,791$0.00$0.00
May 15, 2026LI SUSAN JChief Financial OfficerC2,399$0.00$0.00
May 15, 2026LI SUSAN JChief Financial OfficerM6,791$0.00$0.00
May 15, 2026Cox Christopher KChief Product OfficerM6,791$0.00$0.00
May 15, 2026Cox Christopher KChief Product OfficerM6,791$0.00$0.00
May 15, 2026Bosworth AndrewChief Technology OfficerF8,127$618.43$5.0M
May 15, 2026Bosworth AndrewChief Technology OfficerM6,791$0.00$0.00
20 SEC filing reports analyzed. Sentiment: 3 bullish, 2 bearish, 2 mixed, 13 neutral. Avg impact: 3.1/10.
MIXED ANALYST-UPGRADE 2/10
DA Davidson initiates META at Buy — PT $600 (-5.1%)
May 31, 2026
MIXED ANALYST-UPGRADE 2/10
Four firms act on META in cluster — DA Davidson initiates Buy with $600 PT (below current); consensus still bullish with mean target $855
May 1, 2026
NEUTRAL CLUSTER 2/10
Two Meta C-suite executives (COO and CLO) sold a combined $1.79M in open-market sales over the past
Jun 3, 2026
NEUTRAL 144 2/10
Director Robert M. Kimmitt filed a Form 144 notice of intent to sell 504 Class A common shares of Me
Jun 1, 2026
NEUTRAL COURT-RULING 3/10
The court issued an order to show cause questioning whether it has jurisdiction under the Class Acti
Jun 1, 2026
NEUTRAL CLUSTER 2/10
Two senior Meta executives — COO Javier Olivan and Chief Legal Officer Curtis Mahoney — sold a combi
May 29, 2026
NEUTRAL CLUSTER 2/10
Meta Platforms insiders sold a combined $1.88M worth of stock in a cluster window (May 8-15, 2026),
May 20, 2026
BULLISH COURT-RULING 4/10
Meta Platforms and Eight Khz, LLC jointly stipulated to dismiss their cross-appeals from a PTAB inte
May 15, 2026
NEUTRAL CLUSTER 2/10
Two Meta insiders sold a combined $814K in open-market sales over the past week, while CEO Zuckerber
May 12, 2026
NEUTRAL CLUSTER 2/10
Two Meta insiders—COO Javier Olivan and Director Peggy Alford—sold a combined $814K in open-market s
May 6, 2026
NEUTRAL CLUSTER 2/10
Two META insiders (COO Javier Olivan and Director Peggy Alford) sold a total of $872K in shares with
May 5, 2026
NEUTRAL 8-K 4/10
Meta Platforms completed a $25 billion multi-tranche senior note offering, including six tranches ma
May 4, 2026
NEUTRAL 144 2/10
Director Peggy Alford filed a Form 144 to sell 409 shares of Meta Platforms Class A common stock, wi
May 1, 2026
NEUTRAL COURT-RULING 2/10
The Federal Circuit dismissed Meta's appeal in the IPR dispute with Eight Khz LLC by agreement, with
May 1, 2026
NEUTRAL S-3ASR 3/10
Meta filed an automatic shelf registration statement (S-3ASR) to register an indeterminate amount of
Apr 30, 2026
BULLISH COURT-RULING 7/10
The Ninth Circuit affirmed the dismissal of a putative class action against Meta Platforms, holding
Apr 28, 2026
BULLISH COURT-RULING 6/10
A federal court denied defendants' motion to dismiss Meta's lawsuit alleging $8.1 million in fraudul
Apr 21, 2026
BEARISH COURT-RULING 6/10
The Sixth Circuit reversed the dismissal of a tortious interference claim against Merlo S.p.A. Indus
Apr 21, 2026
BEARISH CLUSTER 5/10
Two corporate insiders at Meta Platforms sold shares in the past week, including COO Javier Olivan a
Apr 17, 2026
NEUTRAL DEFA14A 3/10
Meta Platforms, Inc. filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting. This
Apr 16, 2026

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Sep 2024): 88% buy across 72 analysts — 22 strong buy, 41 buy, 9 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Sep 2024. No current recommendation available.
$828.80 mean target (Sep 2024)
$700.00 Low $1,015.00 High
MetricValue
Current Price$593.00
Target Low$700.00
Target Mean$828.80
Target Median$825.00
Target High$1,015.00
# Analysts59
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$7.20 $5.76 $8.55 0.9% +0.1% 22↑ 13↓ $60.2B 26.7% 46
Next Q
2026-09-30
$7.04 $6.05 $8.99 570.7% +0.5% 10↑ 22↓ $63.2B 23.3% 44
Current FY
2026-12-31
$32.90 $29.61 $38.62 40.1% +0.8% 46↑ 1↓ $253.1B 25.9% 55
Next FY
2027-12-31
$34.90 $30.22 $40.86 6.1% +0.9% 24↑ 19↓ $302.2B 19.4% 54

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$7.201
7d ago$7.201
30d ago$7.194+0.007
60d ago$7.127+0.074
90d ago$7.117+0.083
34 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Sep 30, 2024 Cantor Fitzgerald REITERATE Overweight Overweight
Sep 30, 2024 Monness, Crespi, Hardt MAINTAIN Buy Buy
Sep 26, 2024 Rosenblatt MAINTAIN Buy Buy
Sep 26, 2024 B of A Securities MAINTAIN Buy Buy
Sep 26, 2024 JP Morgan MAINTAIN Overweight Overweight
Sep 26, 2024 Wedbush REITERATE Outperform Outperform
Sep 26, 2024 Baird MAINTAIN Outperform Outperform
Sep 26, 2024 JMP Securities MAINTAIN Market Outperform Market Outperform
Sep 23, 2024 Cantor Fitzgerald REITERATE Overweight Overweight
Sep 23, 2024 Citigroup MAINTAIN Buy Buy
Sep 10, 2024 DA Davidson INITIATE Buy
Sep 5, 2024 Cantor Fitzgerald INITIATE Overweight
Sep 4, 2024 Needham REITERATE Underperform
Aug 16, 2024 Tigress Financial MAINTAIN Strong Buy Strong Buy
Aug 6, 2024 Loop Capital MAINTAIN Buy Buy
Aug 1, 2024 JMP Securities MAINTAIN Market Outperform Market Outperform
Aug 1, 2024 Guggenheim MAINTAIN Buy Buy
Aug 1, 2024 Deutsche Bank MAINTAIN Buy Buy
Aug 1, 2024 Keybanc MAINTAIN Overweight Overweight
Aug 1, 2024 Roth MKM MAINTAIN Buy Buy
Aug 1, 2024 Barclays MAINTAIN Overweight Overweight
Aug 1, 2024 BMO Capital MAINTAIN Market Perform Market Perform
Aug 1, 2024 RBC Capital REITERATE Outperform Outperform
Aug 1, 2024 Stifel MAINTAIN Buy Buy
Aug 1, 2024 Truist Securities MAINTAIN Buy Buy
Aug 1, 2024 Susquehanna MAINTAIN Positive Positive
Aug 1, 2024 JP Morgan MAINTAIN Overweight Overweight
Aug 1, 2024 Evercore ISI Group MAINTAIN Outperform Outperform
Aug 1, 2024 Wells Fargo MAINTAIN Overweight Overweight
Aug 1, 2024 UBS MAINTAIN Buy Buy
Aug 1, 2024 Baird MAINTAIN Outperform Outperform
Aug 1, 2024 Citigroup MAINTAIN Buy Buy
Aug 1, 2024 Jefferies MAINTAIN Buy Buy
Aug 1, 2024 Needham REITERATE Underperform
Aug 1, 2024 Rosenblatt MAINTAIN Buy Buy
Aug 1, 2024 Morgan Stanley MAINTAIN Overweight Overweight
Aug 1, 2024 B of A Securities MAINTAIN Buy Buy
Aug 1, 2024 Oppenheimer MAINTAIN Outperform Outperform
Aug 1, 2024 Goldman Sachs MAINTAIN Buy Buy
Jul 30, 2024 JMP Securities REITERATE Market Outperform Market Outperform
Jul 26, 2024 Needham REITERATE Underperform
Jul 25, 2024 Benchmark REITERATE Hold
Jul 24, 2024 Wedbush REITERATE Outperform Outperform
Jul 24, 2024 Needham REITERATE Underperform
Jul 22, 2024 Bernstein MAINTAIN Outperform Outperform
Jul 19, 2024 Oppenheimer MAINTAIN Outperform Outperform
Jul 16, 2024 Wolfe Research INITIATE Outperform
Jul 10, 2024 TD Cowen MAINTAIN Buy Buy
Jul 8, 2024 Wells Fargo MAINTAIN Overweight Overweight
Jul 3, 2024 Loop Capital REITERATE Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 2026224190088%
May 1, 2026244090088%
Apr 1, 2026224280089%
Mar 1, 2026214470090%
Feb 1, 2026214470090%
Jan 1, 2026214370090%
Dec 1, 2025224480089%
Nov 1, 20252242101085%
Strong BuyBuyHoldSellStrong Sell
7 members of Congress traded this stock: 8 buys, 2 sells.

Congressional Trades

DateMemberPartyChamberTypeAmountAssetDisclosed
Apr 17, 2026Michael McCaulRHOUSEBUY$1,001 - $15,000Meta Platforms IncMay 11, 2026 (25d)
Apr 2, 2026Ro KhannaDHOUSEBUY$1,001 - $15,000Meta Platforms IncMay 13, 2026 (42d)
Mar 6, 2026Ro KhannaDHOUSESELL$1,001 - $15,000Meta Platforms IncApr 9, 2026 (35d)
Feb 20, 2026Michael McCaulRHOUSEBUY$1,001 - $15,000Meta Platforms IncMar 12, 2026 (21d)
Feb 13, 2026Angus KingOSENATESELL$1,001 - $15,000Meta Platforms IncMar 24, 2026 (39d)
Feb 12, 2026Julia LetlowRHOUSEBUY$1,001 - $15,000Meta Platforms IncMar 13, 2026 (30d)
Feb 11, 2026Michael McCaulRHOUSEBUY$1,001 - $15,000Meta Platforms IncMar 12, 2026 (30d)
Feb 3, 2026Cleo FieldsDHOUSEBUY$100,001 - $250,000Meta Platforms IncFeb 25, 2026 (23d)
Jan 30, 2026Gilbert CisnerosDHOUSEBUY$1,001 - $15,000Meta Platforms IncFeb 16, 2026 (18d)
Dec 29, 2025Markwayne MullinRSENATEBUY$50,001 - $100,000Meta Platforms IncJan 16, 2026 (19d)
50°
Neutral
Bearish Neutral Bullish
33 mentions 16 bullish 16 bearish 30 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Jun 4, 2026160° Warm101
Jun 3, 2026160° Warm101
Jun 3, 2026160° Warm101
Jun 3, 2026140° Cool011
Jun 3, 2026160° Warm101
Jun 3, 2026160° Warm101
Jun 3, 2026160° Warm101
Jun 3, 2026160° Warm101
Jun 3, 2026140° Cool011
Jun 3, 2026140° Cool011
Jun 2, 2026140° Cool011
Jun 2, 2026140° Cool011
Jun 2, 2026160° Warm101
Jun 1, 2026140° Cool011
Jun 1, 2026140° Cool011
Jun 1, 2026140° Cool011
Jun 1, 2026140° Cool011
May 31, 2026140° Cool011
May 29, 2026267° Warm202
May 29, 2026160° Warm101
May 29, 2026160° Warm101
May 28, 2026160° Warm101
May 28, 2026140° Cool011
May 28, 2026140° Cool011
May 28, 2026160° Warm101
May 28, 2026233° Cool022
May 28, 2026140° Cool011
May 27, 2026140° Cool011
May 27, 2026258° Warm102
May 27, 2026160° Warm101

Recent Reddit Threads

r/wallstreetbets Neutral 3mo ago
CRWV seeks 8.5b loan backed by META deal
▲ 49 💬 63 ⚡ 2.8
r/stockmarket Bearish 4mo ago
The real bubble is in Big Oil, NOT in Big Tech.
▲ 123 💬 61 ⚡ 1.1
r/stockmarket Bullish 3mo ago
AMD is up 14% because of rumored META news.
▲ 24 💬 27 ⚡ 0.8
r/stocks Bullish 26d 14h ago
Tracked my buys this year. Am I setting up for underperformance?
▲ 1 💬 0 ⚡ 0.5
r/investing Bearish 1mo ago
AI Bubble this, AI Bubble that
▲ 1 💬 0 ⚡ 0.5
r/wallstreetbets Neutral 9d 5h ago
Thinking META hits $700 by 6/26 expiration
▲ 1 💬 1 ⚡ 0.5
r/wallstreetbets Bullish 7d 20h ago
META is the best value play that will 5X - 40k Yolo
▲ 2 💬 0 ⚡ 0.5
r/options Bullish 2d 8h ago
META: Big Call Flow, But This Looks More Like a $615 Pin Than a Breakout
▲ 1 💬 0 ⚡ 0.5
r/stocks Neutral 2mo ago
META, MELI or RDDT
▲ 1 💬 0 ⚡ 0.5
r/investing Bullish 1d 9h ago
Comparing Cash Flow Valuations Across Leading Tech Giants
▲ 1 💬 0 ⚡ 0.5
r/pennystocks Neutral 1mo ago
Delivery Day $VTIX, Hitting the Healthcare Market
▲ 1 💬 1 ⚡ 0.5
r/investing Neutral 2mo ago
Posting my Deep Dive Stock Research Thesis on META on Substack here!
▲ 1 💬 1 ⚡ 0.5
r/options Neutral 1mo ago
CSSP vs. Put Spread
▲ 1 💬 0 ⚡ 0.5
r/stocks Bearish 2mo ago
It’s weird how investment works sometimes.
▲ 1 💬 0 ⚡ 0.5
r/investing Bearish 2mo ago
UNH average price at 270USD
▲ 1 💬 0 ⚡ 0.5
r/stocks Bullish 27d 19h ago
AI materials vs. AI companies
▲ 1 💬 0 ⚡ 0.5
r/wallstreetbets Bearish 1mo ago
Holding META/METU into the weekend hoping for a a turnaround
▲ 1 💬 1 ⚡ 0.5
r/investing Bullish 29d 7h ago
21 Y/O Portfolio Breakdown (Advice Welcomed)
▲ 1 💬 0 ⚡ 0.5
Jul 28, 2026
earnings_calendar
META Q2 2026 Earnings After Market Close — 2026-07-28
EPS est: $7.37 | Rev est: $60.7B
Jun 5, 2026
options_unusual
Unusual Call: META $655 2026-07-17 — $1.8M premium
Vol: 1,003 vs OI: 1,650 (0.6x). Price: $19.00, IV: 33%, Delta: 0.38. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $635 2026-06-05 — $1.2M premium
Vol: 1,746 vs OI: 2,934 (0.6x). Price: $6.65, IV: 50%, Delta: 0.47. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $627.5 2026-06-05 — $1.2M premium
Vol: 1,131 vs OI: 1,513 (0.7x). Price: $10.45, IV: 50%, Delta: 0.62. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $630 2026-06-12 — $1.6M premium
Vol: 965 vs OI: 2,450 (0.4x). Price: $16.41, IV: 38%, Delta: 0.55. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $640 2026-06-05 — $1.6M premium
Vol: 3,264 vs OI: 4,925 (0.7x). Price: $4.90, IV: 51%, Delta: 0.37. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $625 2026-06-05 — $1.6M premium
Vol: 1,359 vs OI: 3,701 (0.4x). Price: $12.25, IV: 49%, Delta: 0.67. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $650 2026-06-12 — $2.8M premium
Vol: 3,296 vs OI: 4,206 (0.8x). Price: $8.40, IV: 40%, Delta: 0.34. Direction: UNKNOWN
Jun 4, 2026
options_unusual
Unusual Call: META $630 2026-06-05 — $3.5M premium
Vol: 3,861 vs OI: 5,549 (0.7x). Price: $9.15, IV: 49%, Delta: 0.57. Direction: UNKNOWN
Jun 3, 2026
Clinical Trial
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD
Phase Phase 3 — COMPLETED
Jun 3, 2026
options_unusual
Unusual Call: META $600 2027-06-17 — $8.3M premium
Vol: 735 vs OI: 2,338 (0.3x). Price: $112.00, IV: 39%, Delta: 0.64. Direction: UNKNOWN
Jun 3, 2026
options_unusual
Unusual Call: META $610 2026-06-03 — $1.7M premium
Vol: 2,502 vs OI: 2,536 (1x). Price: $7.00, IV: 72%, Delta: 0.61. Direction: UNKNOWN
Jun 3, 2026
options_unusual
Unusual Call: META $605 2026-06-03 — $2.0M premium
Vol: 2,016 vs OI: 1,764 (1.1x). Price: $10.00, IV: 70%, Delta: 0.75. Direction: OPENING
Jun 3, 2026
options_unusual
Unusual Call: META $720 2026-08-21 — $8.9M premium
Vol: 5,233 vs OI: 14,428 (0.4x). Price: $16.50, IV: 43%, Delta: 0.26. Direction: UNKNOWN
Jun 3, 2026
Enforcement
Layout, Inc. v. Heavy Metal Corp.
Court ruling from Appellate Division of the Supreme Court of the State of New York. Docket: 2021-04937
Jun 1, 2026
options_unusual
Unusual Put: META $720 2026-06-18 — $16.0M premium
Vol: 1,520 vs OI: 3,558 (0.4x). Price: $107.30, IV: 50%, Delta: -0.94. Direction: UNKNOWN
May 28, 2026
options_unusual
Unusual Call: META $640 2026-05-29 — $7.8M premium
Vol: 10,851 vs OI: 9,888 (1.1x). Price: $7.17, IV: 48%, Delta: 0.50. Direction: OPENING
May 21, 2026
Clinical Trial
Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.
Phase Phase 3 — COMPLETED
May 15, 2026
Enforcement
Meta Platforms, Inc. v. Eight Khz, LLC
Court ruling from Court of Appeals for the Federal Circuit. Docket: 25-1528
May 15, 2026
Enforcement
Nikko D'Ambrosio v. Meta Platforms, Inc.
Court ruling from Court of Appeals for the Seventh Circuit. Docket: 25-2231
May 1, 2026
Enforcement
Meta Platforms, Inc. v. Eight Khz, LLC
Court ruling from Court of Appeals for the Federal Circuit. Docket: 25-1514
Apr 29, 2026
Clinical Trial
Efficacy of Bumetanide in Children With Autism Spectrum Disorder Guided by Peripheral Blood Biomarkers and Machine Learning Models
Phase Phase 2 — COMPLETED
Apr 28, 2026
Enforcement
Commission preliminarily finds Meta in breach of Digital Services Act for failing to prevent minors under 13 from using Instagram and Facebook
European Commission Press release Brussels, 29 Apr 2026 The European Commission has preliminarily found Meta's Instagram and Facebook in breach of the
Apr 1, 2026
Clinical Trial
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
Phase Phase 2 — TERMINATED
Mar 12, 2026
Clinical Trial
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Phase Phase 3 — COMPLETED